CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 of $1.47 million for the 3-month period ending 2014-03-29, per its 10-Q filed 2014-04-30.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 · last filed 2014-04-30
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers out of level 3 for the quarter ending 2014-03-29 was $1.47M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers out of level 3 for the quarter ending 2013-09-28 was $2.63M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 9 month |
|---|---|---|---|
| 2014-03-29 | $1.47M 10-Q · filed 2014-04-30 | ||
| 2013-09-28 | $2.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $4.91M 10-Q · filed 2013-10-30 | |
| 2013-06-29 | $2.27M 10-Q · filed 2013-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |